Skip to content

Glucose Containing and Glucose Free Hemodialysate in Type 2 Diabetic Patients

Glucose Control During Glucose Containing And Glucose Free Hemodialysate Evaluated By Continuous Glucose Monitoring In Type 2 Diabetic Patients

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02009514
Enrollment
10
Registered
2013-12-12
Start date
2002-10-31
Completion date
2004-03-31
Last updated
2020-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-Stage Kidney Disease, Type 2 Diabetes Mellitus

Keywords

Hemodialysis, Continuous glucose monitoring, Hypoglycemia, Hyperglycemia

Brief summary

The purpose of this study is to investigate differences in glycemia * during the whole hemodialysis day and the whole freeday * during hemodialysis, during the evening and the night after hemodialysis and at the same time intervals during the freeday in an unselected type 2 diabetic patient group using both glucose-containing and glucose-free dialysate.

Interventions

OTHERGlucose-containing compared to glucose-free hemodialysate

Comparison of effects on glucose variation

Sponsors

Tampere University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* type 2 diabetic patient * undergoing stable intermittent thrice weekly hemodialysis for at least one month

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Glucose below 4.0 mmol/lIn the end of a two week periodIn the end of a two-week glucose-containing and glucose-free period percentage of hypoglycemic values of continuous glucose monitoring during the whole hemodialysis day is compared to the whole freeday. Similar comparison is made between the whole glucose-containing and the whole glucose-free hemodialysis day as well as between the whole glucose-containing and the whole glucose-free freeday.

Secondary

MeasureTime frameDescription
Glucose below 4.0 mmol/l during specified time intervalsIn the end of a two-week periodPercentage of hypoglycemia during the specified time intervals is compared within the glucose-containing and glucose-free hemodialysis day and freeday, and between the glucose-containing and glucose-free hemodialysis day and the freeday. Lastly comparisons are made between the glucose-containing and glucose-free hemodialysis day, and between the glucose-containing and glucose-free freeday.

Other

MeasureTime frameDescription
Glucose above 10.0 mmol/lIn the end of a two-week periodPercentage of hyperglycemic values of continuous glucose monitoring during the whole glucose-containing and glucose-free hemodialysis day is compared to the whole glucose-containing and glucose-free freeday, respectively. Similar comparison is made between the whole glucose-containing and glucose-free hemodialysis day and between the whole glucose-containing and glucose-free freeday.
Glucose above 10.0 mmol/l during specified time intervalsIn the end of a two-week periodPercentage of hyperglycemia during the specified time intervals is compared within the glucose-containing and glucose-free hemodialysis day and freeday, and between the glucose-containing and glucose-free hemodialysis day and the freeday. Lastly comparisons are made between the glucose-containing and glucose-free hemodialysis day, and between the glucose-containing and glucose-free freeday.
Mean glucoseIn the end of a two-week periodMean glucose of continuous glucose monitoring during the whole glucose-containing and glucose-free hemodialysis day is compared to the whole glucose-containing and glucose-free freeday, respectively. Similar comparison is made between the whole glucose-containing and glucose-free hemodialysis day and between the whole glucose-containing and glucose-free freeday.
Standard deviation of glucose during specified time intervalsIn the end of a two-week periodStandard deviation of glucose during the specified time intervals is compared within the glucose-containing and glucose-free hemodialysis day and freeday, and between the glucose-containing and glucose-free hemodialysis day and the freeday. Lastly comparisons are made between the glucose-containing and glucose-free hemodialysis day, and between the glucose-containing and glucose-free freeday.
Standard deviation of glucoseIn the end of a two-week periodStandard deviation of glucose of continuous glucose monitoring during the whole glucose-containing and glucose-free hemodialysis day is compared to the whole glucose-containing and glucose-free freeday, respectively. Similar comparison is made between the whole glucose-containing and glucose-free hemodialysis day and between the whole glucose-containing and glucose-free freeday.
Mean glucose during specified time intervalsIn the end of a two-week periodMean glucose during the specified time intervals is compared within the glucose-containing and glucose-free hemodialysis day and freeday, and between the glucose-containing and glucose-free hemodialysis day and the freeday. Lastly comparisons are made between the glucose-containing and glucose-free hemodialysis day, and between the glucose-containing and glucose-free freeday.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026